28 August: Sodium Chondroitin sulfate is mostly used to treat cataract, osteoarthritis, urinary tract infections. It is used as a medicine to improve digestive function, lower blood sugar, enhanced liver function, and inhibit tumor metastasis. A human body produces chondroitin sulfate, a chemical in cartilage around joints in the body. It is usually manufactured from animal sources, such as shark and cow cartilage. It is often used in combination with other ingredients, including manganese ascorbate, hyaluronic acid, and glucosamine.
High Demand for Product to Treat Eye Complications
Based on source, sodium chondroitin sulfate market can be segmented as bovine, swine, poultry, shark, and synthetic. The bovine segment is further segmented into nutraceuticals, pharmaceuticals, animal feed, personal care & cosmetics, and others. Bovine segment accounted for the largest segment in 2018 due to its usage in various applications including nutraceuticals, animal feed, and pharmaceuticals. A byproduct of beef industry is bovine cartilage and it is generated on a large scale around the world. For human consumption, cattle byproducts are used in various parts of the world. As a source for producing sodium chondroitin sulfate, these factors have prompted manufacturers to opt for bovine.
Owing to its ability to treat eye complications, arthritis, and heal wounds, shark derived chondroitin sulfate is generally used in pharmaceutical sector. A factor that is posing a challenge to the growth of chondroitin sulfate market is that sharks are endangered species and it is prohibited to harm the sea creatures. However, sodium chondroitin sulfate retrieved from shark is used due to its ability to treat people infected with arthritis, intestine inflammation, and HIV, which is fueling the growth of the sodium chondroitin sulfate market.
Synthetic chondroitin is manufactured using a two-stage fermentation-based process. The occurrence of adulteration and contamination is reduced as the process excludes the use of animal cartilages. This also results in the extraction process becoming less complicated leading to low production cost.
Market Insights
Factors such as increasing prevalence of arthritis among geriatric population and increasing rate of obesity has led to increased consumption of joint health supplements, which is driving the demand for sodium chondroitin sulfate. Joint health benefits and clinical efficacy are major factors promoting the market growth. Pharmaceutical grade sodium chondroitin sulfate is being increasingly used to cure osteoarthritis driving industry growth. Manufacturers and raw material suppliers have numerous opportunities to supply quality and uniform products through auditable supply chain.
Some of the leading companies of the sodium chondroitin sulfate market are Qingdao Wan tulmin Biological Products Co. Ltd.; TSI Group Ltd.; BRF; Bioiberica S.A.U.; HeBei SanXin Industrial Group; Sigma-Aldrich, Inc.; Bio-gen Extracts Private Limited; Sino Siam Biotechnique Company Limited; ZPD; and SEIKAGAKU CORPORATION.
No comments:
Post a Comment